Bharat Biotech company is set to release its Kovid-19 vaccine Kovaxin (COVAXIN) from Rajiv Gandhi International Airport here on Tuesday evening. A senior official of the airport’s freight department gave this information. Covaxine has received emergency approval from the Drug Controller General of India.
Officials told reporters after receiving the first batch of Kovishield vaccines, “Today we received the first batch of vaccines from the Serum Institute at Hyderabad Airport. We received a consignment of 970 kg. “He said,” The first consignment of India Biotech vaccines is going to depart from Hyderabad this evening. It will leave for 11 places.
Kovishield has been developed by Oxford University and the British-Swedish company AstraZeneca and is being produced in India by Pune-based Serum Institute of India. Kovaxin has been developed indigenously by Bharat Biotech along with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
An e-mail sent to Bharat Biotech to find out about the program for supply of covacine was responded to.
(This news has not been edited by the NewsBust team. It is published directly from the Syndicate feed.)